Bruker sees Q4 revenue up low single digits year-over-year

During its presentation at the J.P. Morgan Healthcare Conference, Bruker stated that its current preliminary expectation for revenue for Q4 to be up low single digits percent year-over-year, a result of organic growth of mid-to-high single digits percent year-over-year, foreign currency translation headwind of about 7% year-over-year and acquisition contributing about 2% to growth year-over-year.